These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30906213)

  • 1. Repression of Hexokinases II-Mediated Glycolysis Contributes to Piperlongumine-Induced Tumor Suppression in Non-Small Cell Lung Cancer Cells.
    Zhou L; Li M; Yu X; Gao F; Li W
    Int J Biol Sci; 2019; 15(4):826-837. PubMed ID: 30906213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol inhibits Hexokinases II mediated glycolysis in non-small cell lung cancer via targeting Akt signaling pathway.
    Li W; Ma X; Li N; Liu H; Dong Q; Zhang J; Yang C; Liu Y; Liang Q; Zhang S; Xu C; Song W; Tan S; Rong P; Wang W
    Exp Cell Res; 2016 Dec; 349(2):320-327. PubMed ID: 27829129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deguelin inhibits non-small cell lung cancer via down-regulating Hexokinases II-mediated glycolysis.
    Li W; Gao F; Ma X; Wang R; Dong X; Wang W
    Oncotarget; 2017 May; 8(20):32586-32599. PubMed ID: 28427230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xanthohumol inhibits colorectal cancer cells via downregulation of Hexokinases II-mediated glycolysis.
    Liu W; Li W; Liu H; Yu X
    Int J Biol Sci; 2019; 15(11):2497-2508. PubMed ID: 31595166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piperlongumine inhibits lung tumor growth via inhibition of nuclear factor kappa B signaling pathway.
    Zheng J; Son DJ; Gu SM; Woo JR; Ham YW; Lee HP; Kim WJ; Jung JK; Hong JT
    Sci Rep; 2016 May; 6():26357. PubMed ID: 27198178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sinomenine Inhibits Non-Small Cell Lung Cancer via Downregulation of Hexokinases II-Mediated Aerobic Glycolysis.
    Liu W; Yu X; Zhou L; Li J; Li M; Li W; Gao F
    Onco Targets Ther; 2020; 13():3209-3221. PubMed ID: 32368080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Licochalcone A suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the Akt signaling pathway.
    Wu J; Zhang X; Wang Y; Sun Q; Chen M; Liu S; Zou X
    Oncol Rep; 2018 Mar; 39(3):1181-1190. PubMed ID: 29286170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
    Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J
    PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piperlongumine induces apoptosis and autophagy in human lung cancer cells through inhibition of PI3K/Akt/mTOR pathway.
    Wang F; Mao Y; You Q; Hua D; Cai D
    Int J Immunopathol Pharmacol; 2015 Sep; 28(3):362-73. PubMed ID: 26246196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAF6 Promoted Tumor Glycolysis in Non-Small-Cell Lung Cancer by Activating the Akt-HIF
    Feng L; Feng S; Nie Z; Deng Y; Xuan Y; Chen X; Lu Y; Liang L; Chen Y
    Biomed Res Int; 2021; 2021():3431245. PubMed ID: 34409101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
    Gong T; Cui L; Wang H; Wang H; Han N
    J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of insulin-like growth factor binding protein-3 and farnesyltransferase inhibitor SCH66336 on Akt expression and apoptosis in non-small-cell lung cancer cells.
    Lee HY; Moon H; Chun KH; Chang YS; Hassan K; Ji L; Lotan R; Khuri FR; Hong WK
    J Natl Cancer Inst; 2004 Oct; 96(20):1536-48. PubMed ID: 15494604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of miR-214 inhibits proliferation and glycolysis in non-small-cell lung cancer cells via down-regulating the expression of hexokinase 2 and pyruvate kinase isozyme M2.
    Zhang K; Zhang M; Jiang H; Liu F; Liu H; Li Y
    Biomed Pharmacother; 2018 Sep; 105():545-552. PubMed ID: 29886375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jolkinolide B inhibits glycolysis by downregulating hexokinase 2 expression through inactivating the Akt/mTOR pathway in non-small cell lung cancer cells.
    Gao X; Han H
    J Cell Biochem; 2018 Jun; 119(6):4967-4974. PubMed ID: 29384225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-206 regulates non-small-cell lung cancer cell aerobic glycolysis by targeting hexokinase 2.
    Jia KG; Feng G; Tong YS; Tao GZ; Xu L
    J Biochem; 2020 Apr; 167(4):365-370. PubMed ID: 31742336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC.
    Yang C; Wang H; Zhang B; Chen Y; Zhang Y; Sun X; Xiao G; Nan K; Ren H; Qin S
    J Exp Clin Cancer Res; 2016 Sep; 35(1):158. PubMed ID: 27737687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
    Pang L; Han S; Jiao Y; Jiang S; He X; Li P
    Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligustilide inhibits the proliferation of non-small cell lung cancer via glycolytic metabolism.
    Jiang X; Zhao W; Zhu F; Wu H; Ding X; Bai J; Zhang X; Qian M
    Toxicol Appl Pharmacol; 2021 Jan; 410():115336. PubMed ID: 33212065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calpain-2 Enhances Non-Small Cell Lung Cancer Progression and Chemoresistance to Paclitaxel via EGFR-pAKT Pathway.
    Xu F; Gu J; Lu C; Mao W; Wang L; Zhu Q; Liu Z; Chu Y; Liu R; Ge D
    Int J Biol Sci; 2019; 15(1):127-137. PubMed ID: 30662353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piperlongumine analogue L50377 induces pyroptosis via ROS mediated NF-κB suppression in non-small-cell lung cancer.
    Li Q; Chen L; Dong Z; Zhao Y; Deng H; Wu J; Wu X; Li W
    Chem Biol Interact; 2019 Nov; 313():108820. PubMed ID: 31518571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.